Evidence map›Paper›PMID 32805549›Full record

ArticleDrug and alcohol dependence2020

A prospective study of the association between rate of nicotine metabolism and alcohol use in tobacco users in the United States.

Walter Roberts, Phillip L Marotta, Terril L Verplaetse, MacKenzie R Peltier, Catherine Burke, Vijay A Ramchandani, Sherry A McKee

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Walter RobertsDepartment of Psychiatry, Yale School of Medicine, United States. Electronic address: walter.roberts@yale.edu.
Phillip L MarottaDepartment of Psychiatry, Yale School of Medicine, United States.
Terril L VerplaetseDepartment of Psychiatry, Yale School of Medicine, United States.
MacKenzie R PeltierDepartment of Psychiatry, Yale School of Medicine, United States; Veterans Affairs Connecticut Healthcare System, United States.
Catherine BurkeDepartment of Psychiatry, Yale School of Medicine, United States.
Vijay A RamchandaniSection on Human Psychopharmacology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, United States.
Sherry A McKeeDepartment of Psychiatry, Yale School of Medicine, United States.
Yale University · USNational Institutes of Health · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Alcohol Pharmacokinetics and Pharmacodynamics in HumansZIAAA000466 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI RAMCHANDANI, VIJAY ARJUN · 2009 to 2025
$31.2M
Yale-SCORE Resource Support CoreU54AA027989 · NIAAA · YALE UNIVERSITY · PI Sherry Ann McKee · 2020 to 2026
$13.0M
Research Training Program in Substance Use PreventionT32DA019426 · NIDA · YALE UNIVERSITY · PI TAMI P SULLIVAN · 2005 to 2026
$7.5M
Sex-Appropriate Treatment Development for Alcohol Use DisordersP01AA027473 · NIAAA · YALE UNIVERSITY · PI MCKEE, SHERRY ANN · 2018 to 2019
$1.0M
Behavioral and Neurochemical Mechanisms Underlying Stress-Precipitated DrinkingK01AA025670 · NIAAA · YALE UNIVERSITY · PI VERPLAETSE, TERRIL L · 2018 to 2023
$882k
Developing a mobile alcohol biosensor platform for use in medication testing researchK23AA026890 · NIAAA · YALE UNIVERSITY · PI ROBERTS, WALTER MCRAINEY · 2019 to 2023
$827k
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS K01 AA025670NIAAA NIH HHS K23 AA026890NIAAA NIH HHS P01 AA027473NIAAA NIH HHS U54 AA027989NIDA NIH HHS T32 DA019426
6 · The paper itself

Abstract

backgroundRate of nicotine metabolism has been identified as a biochemical risk factor for nicotine use and dependence; however, its role in alcohol consumption and related outcomes is not well understood. The current research examined nicotine metabolism rate as a risk factor for alcohol use among current tobacco users. We also examined sex differences in these associations.

methodData were taken from Waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) study, a national longitudinal study of tobacco use and associated health outcomes. The nicotine metabolite ratio (NMR) was calculated as the ratio of trans-3' hydroxycotinine to cotinine in urine samples provided at wave 1. Alcohol use outcomes included past 30-day NIAAA-defined hazardous drinking status, total drinks, and alcohol-related consequences. All analyses controlled for alcohol use at Wave 1.

resultsNMR at Wave 1 predicted increased odds of meeting hazardous drinking criteria, adjusted odds ratio (aOR) = 1.14, 95 % CI = 1.06; 1.23, p = 0.001, greater total alcohol consumption amount, adjusted rate ratio (aRR) = 1.21, 95 % CI = 1.12; 1.30, p <  0.001, and more alcohol consequences, aRR = 1.07, 95 % CI = 1.01; 1.13, p =  0.018, at wave 2. No significant sex differences were identified. NMR remained a significant predictor of alcohol use in models controlling for severity of nicotine exposure in cigarette smokers.

conclusionsNMR may be a shared risk factor for harmful nicotine and alcohol use that contributes to their co-occurrence.

Indexed as

AdultAlcohol DrinkingCotinineFemaleHumansLongitudinal StudiesMaleMiddle AgedNational Institute on Alcohol Abuse and Alcoholism (U.S.)NicotineProspective StudiesRisk FactorsSmokersTobacco ProductsUnited StatesCotininehydroxycotinineNicotineAlcohol useNicotine metabolite ratioRisk factorsTobacco use

Identifiers

PMID32805549
PMCPMC7609495
OpenAlexW3047210216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.